Certification: | ISO, FDA, HACCP |
---|---|
Assay Method: | HPLC |
Application Form: | Paste, Tablet, Capsule |
Application: | Food, Health Care Products |
State: | Powder |
Extract Source: | Red Clover |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Product Name: Red Clover Extract
Botanic Name: Trifolium Pratense
Specification: 8.0% 16.0% 40.0% Isoflavines
Test Method:HPLC
Part of used: Flower
Appearance: Brown fine powder
PRODUCT SPECIFICATIONS | ||
Product Name: | Red clover extract | |
Botanic Name: | Trifolium Pratense L | |
Scientific name(Family/Genus/Species) | Fabaceae/Trifolium/T.pratense | |
Part of plant | Flower | |
Solvent extraction | 20% Water & 80% ethanol | |
Country of Origin: | China | |
Excipent | 10% maltodextrin | |
ANALYSIS ITEMS | SPECIFICATION | TEST METHOD |
Appearance | Fine powder | Organoleptic |
Color | Brown | Visual |
Odour & Taste | Characteristic | Organoleptic |
Identification | Identical to R.S. sample | HPTLC |
Isoflavones | 8.0% 16.0% 40.0% | HPLC |
Solubility | Not soluble in water | Organoleptic |
Hydrocarbons PAHs | ≤ 50 ppb -Reg.UE 1933/2015 | GC-MS |
Benzo(a)pyren | ≤ 10 ppb -Reg.UE 1933/2015 | GC-MS |
Radioactivity | ≤ 600 Bq/Kg -Reg. CE 1409/2009 | Gamma spectrometry |
Apparent density | 0.4-0.7g/ml | Eur.Ph. <2.9.34> |
Sieve Analysis | 100% through 80 mesh | USP39 <786> |
Loss on drying | ≤ 5.0% | Eur.Ph.9.0 [2.5.12] |
Total Ash | ≤ 5.0% | Eur.Ph.9.0 [2.4.16] |
Lead (Pb) | ≤ 3.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
Arsenic (As) | ≤ 1.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
Cadmium(Cd) | ≤ 1.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
Mercury(Hg) | ≤ 0.1 mg/kg -Reg.EC629/2008 | Eur.Ph.9.0<2.2.58>ICP-MS |
Heavy metal | ≤ 10.0 mg/kg | Eur.Ph.9.0 <2.4.8> |
Solvents Residue | Conform Eur.ph. 9.0 <5,4 > and EC European Directive 2009/32 | Eur.Ph.9.0<2.4.24> |
Pesticides Residues | Conform Regulations(EC) No.396/2005 including annexes and successive updates Reg.2008/839/CE | Gas Chromatography |
Aerobic bacteria(TAMC) | ≤1000 cfu/g | USP39 <61> |
Yeast/Moulds(TAMC) | ≤100 cfu/g | USP39 <61> |
Bile-tol.gram- b./Enterobact.: | ≤100 cfu/g | |
Escherichia coli: | Absent in 1g | USP39 <62> |
Salmonella spp: | Absent in 25g | USP39 <62> |
Staphylococcus aureus: | Absent in 1g | |
Listeria Monocytogenens | Absent in 25g | |
Aflatoxins B1 | ≤ 5 ppb -Reg.EC 1881/2006 | USP39 <62> |
Aflatoxins ∑ B1, B2, G1, G2 | ≤ 10 ppb -Reg.EC 1881/2006 | USP39 <62> |
1.Red clover could Improve health, anti-spasm, known for healing properties.
2. Red clover has Treatment of skin diseases (such as eczema, burns, ulcers, psoriasis),
3.Red clover has Treatment of respiratory discomfort (such as asthma, bronchitis, intermittent cough)
4. Red clover have anti-cancer activity and prevention of prostate disease.
5. Most valuable of Red clover estrogen-like effect and alleviate breast pain suffering. Isoflavones play in a weak estrogen, estrogen reduces the number and thus alleviate the suffering.
6. Red clover could maintain bone mineral density in postmenopausal women
7. Red clover could raise high density lipoprotein cholesterol.
Application:
1.In pharmaceutical field
2.In health product field
3.In Cosmetic field
Suppliers with verified business licenses